Metlife (NYSE:MET) had its target price upped by UBS Group from $45.00 to $48.00 in a research report sent to investors on Tuesday morning, AnalystRatings.com reports. The firm currently has a neutral rating on the financial services provider’s stock.

Several other research firms have also issued reports on MET. Wells Fargo & Co set a $60.00 target price on shares of Metlife and gave the stock a buy rating in a research note on Thursday, December 13th. Bank of America upgraded shares of Metlife from a neutral rating to a buy rating and set a $44.06 target price for the company in a research note on Wednesday, January 16th. Argus reiterated a buy rating on shares of Metlife in a research note on Tuesday, February 12th. Sandler O’Neill lowered shares of Metlife from a buy rating to a hold rating and set a $50.00 price target for the company. in a research report on Tuesday, March 19th. Finally, ValuEngine lowered shares of Metlife from a hold rating to a sell rating in a research report on Wednesday, March 20th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. The company has an average rating of Hold and an average target price of $52.84.

NYSE MET opened at $44.30 on Tuesday. Metlife has a 1 year low of $37.76 and a 1 year high of $48.92. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.14 and a quick ratio of 0.14. The firm has a market capitalization of $43.09 billion, a PE ratio of 8.22, a PEG ratio of 0.97 and a beta of 1.19.

Metlife (NYSE:MET) last posted its earnings results on Wednesday, February 6th. The financial services provider reported $1.35 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.05. Metlife had a net margin of 7.53% and a return on equity of 10.24%. The firm had revenue of $15.40 billion during the quarter, compared to analyst estimates of $15.84 billion. During the same quarter in the prior year, the business posted $0.64 EPS. The business’s revenue was up .0% compared to the same quarter last year. Analysts forecast that Metlife will post 5.48 earnings per share for the current fiscal year.

In other Metlife news, EVP Steven J. Goulart sold 10,292 shares of the company’s stock in a transaction dated Tuesday, February 12th. The shares were sold at an average price of $44.40, for a total transaction of $456,964.80. Following the sale, the executive vice president now directly owns 93,214 shares of the company’s stock, valued at $4,138,701.60. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO John D. Mccallion sold 2,669 shares of the company’s stock in a transaction dated Tuesday, February 12th. The shares were sold at an average price of $44.43, for a total transaction of $118,583.67. Following the sale, the chief financial officer now directly owns 20,538 shares in the company, valued at $912,503.34. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MET. Banced Corp lifted its holdings in shares of Metlife by 3.0% in the fourth quarter. Banced Corp now owns 8,156 shares of the financial services provider’s stock worth $335,000 after buying an additional 236 shares in the last quarter. Wetherby Asset Management Inc. lifted its holdings in shares of Metlife by 1.6% in the fourth quarter. Wetherby Asset Management Inc. now owns 15,615 shares of the financial services provider’s stock worth $641,000 after buying an additional 239 shares in the last quarter. Adirondack Trust Co. lifted its holdings in shares of Metlife by 3.2% in the fourth quarter. Adirondack Trust Co. now owns 8,196 shares of the financial services provider’s stock worth $337,000 after buying an additional 256 shares in the last quarter. Fulton Bank N.A. lifted its holdings in shares of Metlife by 4.1% in the fourth quarter. Fulton Bank N.A. now owns 6,637 shares of the financial services provider’s stock worth $272,000 after buying an additional 262 shares in the last quarter. Finally, San Francisco Sentry Investment Group CA lifted its holdings in shares of Metlife by 22.5% in the fourth quarter. San Francisco Sentry Investment Group CA now owns 1,433 shares of the financial services provider’s stock worth $59,000 after buying an additional 263 shares in the last quarter. 76.85% of the stock is currently owned by institutional investors and hedge funds.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Further Reading: What is the Producer Price Index (PPI)?

Analyst Recommendations for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.